nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—Capecitabine—kidney cancer	0.727	1	CbGbCtD
Cidofovir—TYMP—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00224	0.181	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—DAPK1—kidney cancer	0.00152	0.122	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—PPAT—kidney cancer	0.00113	0.0908	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—APRT—kidney cancer	0.00105	0.0844	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—BRAF—kidney cancer	0.000486	0.0392	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDH1—kidney cancer	0.000476	0.0384	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDKN2A—kidney cancer	0.00042	0.0339	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—ERBB2—kidney cancer	0.000402	0.0324	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CCND1—kidney cancer	0.000355	0.0286	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—VEGFA—kidney cancer	0.000309	0.025	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—MYC—kidney cancer	0.000285	0.023	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—MAPK1—kidney cancer	0.000278	0.0225	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000248	0.02	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—TP53—kidney cancer	0.000234	0.0189	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—TP53—kidney cancer	0.000222	0.0179	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ACY1—kidney cancer	0.000148	0.0119	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PDHB—kidney cancer	0.000125	0.0101	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CCBL1—kidney cancer	0.000118	0.00951	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000113	0.0091	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GLIPR1—kidney cancer	0.000102	0.00825	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PPAT—kidney cancer	0.000102	0.00825	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	9.98e-05	0.00805	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—APRT—kidney cancer	9.5e-05	0.00767	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—FH—kidney cancer	9.5e-05	0.00767	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GPC3—kidney cancer	8.94e-05	0.00721	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CA2—kidney cancer	8.69e-05	0.00701	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ALAD—kidney cancer	8.47e-05	0.00684	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ST3GAL2—kidney cancer	8.27e-05	0.00667	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ALDH1A1—kidney cancer	8.08e-05	0.00652	CbGpPWpGaD
Cidofovir—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.98e-05	0.000306	CcSEcCtD
Cidofovir—Discomfort—Paclitaxel—kidney cancer	7.97e-05	0.000306	CcSEcCtD
Cidofovir—Gastrointestinal pain—Vincristine—kidney cancer	7.97e-05	0.000305	CcSEcCtD
Cidofovir—Dizziness—Sorafenib—kidney cancer	7.91e-05	0.000303	CcSEcCtD
Cidofovir—Constipation—Gemcitabine—kidney cancer	7.9e-05	0.000303	CcSEcCtD
Cidofovir—Pain—Gemcitabine—kidney cancer	7.9e-05	0.000303	CcSEcCtD
Cidofovir—Nausea—Erlotinib—kidney cancer	7.9e-05	0.000303	CcSEcCtD
Cidofovir—Alopecia—Capecitabine—kidney cancer	7.9e-05	0.000303	CcSEcCtD
Cidofovir—Dry mouth—Paclitaxel—kidney cancer	7.89e-05	0.000302	CcSEcCtD
Cidofovir—Diarrhoea—Sunitinib—kidney cancer	7.88e-05	0.000302	CcSEcCtD
Cidofovir—Ataxia—Doxorubicin—kidney cancer	7.83e-05	0.0003	CcSEcCtD
Cidofovir—Asthenia—Dactinomycin—kidney cancer	7.82e-05	0.0003	CcSEcCtD
Cidofovir—Confusional state—Paclitaxel—kidney cancer	7.8e-05	0.000299	CcSEcCtD
Cidofovir—Blood creatinine increased—Doxorubicin—kidney cancer	7.8e-05	0.000299	CcSEcCtD
Cidofovir—TYMP—Metabolism—PGK1—kidney cancer	7.75e-05	0.00625	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC5A3—kidney cancer	7.75e-05	0.00625	CbGpPWpGaD
Cidofovir—Dehydration—Doxorubicin—kidney cancer	7.74e-05	0.000297	CcSEcCtD
Cidofovir—Anaphylactic shock—Paclitaxel—kidney cancer	7.74e-05	0.000296	CcSEcCtD
Cidofovir—Oedema—Paclitaxel—kidney cancer	7.74e-05	0.000296	CcSEcCtD
Cidofovir—Abdominal pain—Vincristine—kidney cancer	7.7e-05	0.000295	CcSEcCtD
Cidofovir—Body temperature increased—Vincristine—kidney cancer	7.7e-05	0.000295	CcSEcCtD
Cidofovir—Infection—Paclitaxel—kidney cancer	7.69e-05	0.000295	CcSEcCtD
Cidofovir—Flatulence—Capecitabine—kidney cancer	7.67e-05	0.000294	CcSEcCtD
Cidofovir—Dry skin—Doxorubicin—kidney cancer	7.63e-05	0.000292	CcSEcCtD
Cidofovir—Dysgeusia—Capecitabine—kidney cancer	7.62e-05	0.000292	CcSEcCtD
Cidofovir—Dizziness—Sunitinib—kidney cancer	7.62e-05	0.000292	CcSEcCtD
Cidofovir—Feeling abnormal—Gemcitabine—kidney cancer	7.62e-05	0.000292	CcSEcCtD
Cidofovir—Shock—Paclitaxel—kidney cancer	7.61e-05	0.000292	CcSEcCtD
Cidofovir—Vomiting—Sorafenib—kidney cancer	7.61e-05	0.000292	CcSEcCtD
Cidofovir—Orthostatic hypotension—Doxorubicin—kidney cancer	7.61e-05	0.000291	CcSEcCtD
Cidofovir—TYMP—Metabolism—LDHB—kidney cancer	7.6e-05	0.00613	CbGpPWpGaD
Cidofovir—Nervous system disorder—Paclitaxel—kidney cancer	7.59e-05	0.000291	CcSEcCtD
Cidofovir—Hypokalaemia—Doxorubicin—kidney cancer	7.58e-05	0.00029	CcSEcCtD
Cidofovir—Thrombocytopenia—Paclitaxel—kidney cancer	7.58e-05	0.00029	CcSEcCtD
Cidofovir—Tachycardia—Paclitaxel—kidney cancer	7.55e-05	0.000289	CcSEcCtD
Cidofovir—Rash—Sorafenib—kidney cancer	7.55e-05	0.000289	CcSEcCtD
Cidofovir—Dermatitis—Sorafenib—kidney cancer	7.54e-05	0.000289	CcSEcCtD
Cidofovir—Back pain—Capecitabine—kidney cancer	7.53e-05	0.000288	CcSEcCtD
Cidofovir—Skin disorder—Paclitaxel—kidney cancer	7.52e-05	0.000288	CcSEcCtD
Cidofovir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	7.5e-05	0.000287	CcSEcCtD
Cidofovir—Headache—Sorafenib—kidney cancer	7.5e-05	0.000287	CcSEcCtD
Cidofovir—Muscle spasms—Capecitabine—kidney cancer	7.48e-05	0.000287	CcSEcCtD
Cidofovir—Hyperhidrosis—Paclitaxel—kidney cancer	7.48e-05	0.000287	CcSEcCtD
Cidofovir—Diarrhoea—Dactinomycin—kidney cancer	7.46e-05	0.000286	CcSEcCtD
Cidofovir—Anorexia—Paclitaxel—kidney cancer	7.38e-05	0.000283	CcSEcCtD
Cidofovir—Gastritis—Doxorubicin—kidney cancer	7.37e-05	0.000282	CcSEcCtD
Cidofovir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	7.34e-05	0.000281	CcSEcCtD
Cidofovir—Muscular weakness—Doxorubicin—kidney cancer	7.34e-05	0.000281	CcSEcCtD
Cidofovir—Vomiting—Sunitinib—kidney cancer	7.32e-05	0.000281	CcSEcCtD
Cidofovir—Body temperature increased—Gemcitabine—kidney cancer	7.31e-05	0.00028	CcSEcCtD
Cidofovir—Tremor—Capecitabine—kidney cancer	7.29e-05	0.000279	CcSEcCtD
Cidofovir—Rash—Sunitinib—kidney cancer	7.26e-05	0.000278	CcSEcCtD
Cidofovir—Dermatitis—Sunitinib—kidney cancer	7.26e-05	0.000278	CcSEcCtD
Cidofovir—Hypotension—Paclitaxel—kidney cancer	7.23e-05	0.000277	CcSEcCtD
Cidofovir—Ill-defined disorder—Capecitabine—kidney cancer	7.22e-05	0.000277	CcSEcCtD
Cidofovir—Headache—Sunitinib—kidney cancer	7.22e-05	0.000276	CcSEcCtD
Cidofovir—Dysphagia—Doxorubicin—kidney cancer	7.2e-05	0.000276	CcSEcCtD
Cidofovir—Asthma—Doxorubicin—kidney cancer	7.2e-05	0.000276	CcSEcCtD
Cidofovir—Anaemia—Capecitabine—kidney cancer	7.19e-05	0.000276	CcSEcCtD
Cidofovir—Hypersensitivity—Vincristine—kidney cancer	7.18e-05	0.000275	CcSEcCtD
Cidofovir—Nausea—Sorafenib—kidney cancer	7.11e-05	0.000272	CcSEcCtD
Cidofovir—Pancreatitis—Doxorubicin—kidney cancer	7.06e-05	0.00027	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.05e-05	0.00027	CcSEcCtD
Cidofovir—Malaise—Capecitabine—kidney cancer	7.02e-05	0.000269	CcSEcCtD
Cidofovir—Insomnia—Paclitaxel—kidney cancer	7e-05	0.000268	CcSEcCtD
Cidofovir—Vertigo—Capecitabine—kidney cancer	6.99e-05	0.000268	CcSEcCtD
Cidofovir—Asthenia—Vincristine—kidney cancer	6.99e-05	0.000268	CcSEcCtD
Cidofovir—Syncope—Capecitabine—kidney cancer	6.98e-05	0.000267	CcSEcCtD
Cidofovir—Leukopenia—Capecitabine—kidney cancer	6.96e-05	0.000267	CcSEcCtD
Cidofovir—Paraesthesia—Paclitaxel—kidney cancer	6.95e-05	0.000266	CcSEcCtD
Cidofovir—Vomiting—Dactinomycin—kidney cancer	6.93e-05	0.000266	CcSEcCtD
Cidofovir—Bronchitis—Doxorubicin—kidney cancer	6.92e-05	0.000265	CcSEcCtD
Cidofovir—Dyspnoea—Paclitaxel—kidney cancer	6.9e-05	0.000264	CcSEcCtD
Cidofovir—Somnolence—Paclitaxel—kidney cancer	6.88e-05	0.000264	CcSEcCtD
Cidofovir—Rash—Dactinomycin—kidney cancer	6.87e-05	0.000263	CcSEcCtD
Cidofovir—Nausea—Sunitinib—kidney cancer	6.84e-05	0.000262	CcSEcCtD
Cidofovir—Loss of consciousness—Capecitabine—kidney cancer	6.84e-05	0.000262	CcSEcCtD
Cidofovir—Pancytopenia—Doxorubicin—kidney cancer	6.84e-05	0.000262	CcSEcCtD
Cidofovir—Dyspepsia—Paclitaxel—kidney cancer	6.81e-05	0.000261	CcSEcCtD
Cidofovir—Cough—Capecitabine—kidney cancer	6.79e-05	0.00026	CcSEcCtD
Cidofovir—Dysuria—Doxorubicin—kidney cancer	6.73e-05	0.000258	CcSEcCtD
Cidofovir—Neutropenia—Doxorubicin—kidney cancer	6.73e-05	0.000258	CcSEcCtD
Cidofovir—Decreased appetite—Paclitaxel—kidney cancer	6.73e-05	0.000258	CcSEcCtD
Cidofovir—Hypertension—Capecitabine—kidney cancer	6.72e-05	0.000257	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.68e-05	0.000256	CcSEcCtD
Cidofovir—Diarrhoea—Vincristine—kidney cancer	6.67e-05	0.000255	CcSEcCtD
Cidofovir—Pollakiuria—Doxorubicin—kidney cancer	6.65e-05	0.000255	CcSEcCtD
Cidofovir—Asthenia—Gemcitabine—kidney cancer	6.63e-05	0.000254	CcSEcCtD
Cidofovir—Chest pain—Capecitabine—kidney cancer	6.62e-05	0.000254	CcSEcCtD
Cidofovir—Myalgia—Capecitabine—kidney cancer	6.62e-05	0.000254	CcSEcCtD
Cidofovir—Arthralgia—Capecitabine—kidney cancer	6.62e-05	0.000254	CcSEcCtD
Cidofovir—Constipation—Paclitaxel—kidney cancer	6.62e-05	0.000254	CcSEcCtD
Cidofovir—Pain—Paclitaxel—kidney cancer	6.62e-05	0.000254	CcSEcCtD
Cidofovir—Anxiety—Capecitabine—kidney cancer	6.6e-05	0.000253	CcSEcCtD
Cidofovir—TYMP—Metabolism—CA9—kidney cancer	6.59e-05	0.00532	CbGpPWpGaD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.58e-05	0.000252	CcSEcCtD
Cidofovir—Photosensitivity reaction—Doxorubicin—kidney cancer	6.57e-05	0.000252	CcSEcCtD
Cidofovir—Weight increased—Doxorubicin—kidney cancer	6.55e-05	0.000251	CcSEcCtD
Cidofovir—Discomfort—Capecitabine—kidney cancer	6.54e-05	0.000251	CcSEcCtD
Cidofovir—Pruritus—Gemcitabine—kidney cancer	6.54e-05	0.000251	CcSEcCtD
Cidofovir—Weight decreased—Doxorubicin—kidney cancer	6.51e-05	0.00025	CcSEcCtD
Cidofovir—Hyperglycaemia—Doxorubicin—kidney cancer	6.49e-05	0.000249	CcSEcCtD
Cidofovir—Dry mouth—Capecitabine—kidney cancer	6.48e-05	0.000248	CcSEcCtD
Cidofovir—Nausea—Dactinomycin—kidney cancer	6.48e-05	0.000248	CcSEcCtD
Cidofovir—Pneumonia—Doxorubicin—kidney cancer	6.45e-05	0.000247	CcSEcCtD
Cidofovir—Dizziness—Vincristine—kidney cancer	6.44e-05	0.000247	CcSEcCtD
Cidofovir—Confusional state—Capecitabine—kidney cancer	6.4e-05	0.000245	CcSEcCtD
Cidofovir—Feeling abnormal—Paclitaxel—kidney cancer	6.38e-05	0.000244	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.36e-05	0.000244	CcSEcCtD
Cidofovir—Oedema—Capecitabine—kidney cancer	6.35e-05	0.000243	CcSEcCtD
Cidofovir—Gastrointestinal pain—Paclitaxel—kidney cancer	6.33e-05	0.000242	CcSEcCtD
Cidofovir—Diarrhoea—Gemcitabine—kidney cancer	6.32e-05	0.000242	CcSEcCtD
Cidofovir—Renal failure—Doxorubicin—kidney cancer	6.31e-05	0.000242	CcSEcCtD
Cidofovir—Infection—Capecitabine—kidney cancer	6.31e-05	0.000242	CcSEcCtD
Cidofovir—Neuropathy peripheral—Doxorubicin—kidney cancer	6.29e-05	0.000241	CcSEcCtD
Cidofovir—Jaundice—Doxorubicin—kidney cancer	6.26e-05	0.00024	CcSEcCtD
Cidofovir—Stomatitis—Doxorubicin—kidney cancer	6.26e-05	0.00024	CcSEcCtD
Cidofovir—Shock—Capecitabine—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Cidofovir—Conjunctivitis—Doxorubicin—kidney cancer	6.24e-05	0.000239	CcSEcCtD
Cidofovir—Urinary tract infection—Doxorubicin—kidney cancer	6.24e-05	0.000239	CcSEcCtD
Cidofovir—Nervous system disorder—Capecitabine—kidney cancer	6.23e-05	0.000239	CcSEcCtD
Cidofovir—Thrombocytopenia—Capecitabine—kidney cancer	6.22e-05	0.000238	CcSEcCtD
Cidofovir—Tachycardia—Capecitabine—kidney cancer	6.2e-05	0.000237	CcSEcCtD
Cidofovir—Vomiting—Vincristine—kidney cancer	6.19e-05	0.000237	CcSEcCtD
Cidofovir—Skin disorder—Capecitabine—kidney cancer	6.17e-05	0.000236	CcSEcCtD
Cidofovir—Sweating—Doxorubicin—kidney cancer	6.15e-05	0.000236	CcSEcCtD
Cidofovir—Urticaria—Paclitaxel—kidney cancer	6.15e-05	0.000236	CcSEcCtD
Cidofovir—Rash—Vincristine—kidney cancer	6.14e-05	0.000235	CcSEcCtD
Cidofovir—Hyperhidrosis—Capecitabine—kidney cancer	6.14e-05	0.000235	CcSEcCtD
Cidofovir—Dermatitis—Vincristine—kidney cancer	6.14e-05	0.000235	CcSEcCtD
Cidofovir—Haematuria—Doxorubicin—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Cidofovir—Abdominal pain—Paclitaxel—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Cidofovir—Body temperature increased—Paclitaxel—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Cidofovir—Headache—Vincristine—kidney cancer	6.1e-05	0.000234	CcSEcCtD
Cidofovir—Epistaxis—Doxorubicin—kidney cancer	6.05e-05	0.000232	CcSEcCtD
Cidofovir—Anorexia—Capecitabine—kidney cancer	6.05e-05	0.000232	CcSEcCtD
Cidofovir—Sinusitis—Doxorubicin—kidney cancer	6.02e-05	0.000231	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.95e-05	0.0048	CbGpPWpGaD
Cidofovir—Hypotension—Capecitabine—kidney cancer	5.93e-05	0.000227	CcSEcCtD
Cidofovir—Vomiting—Gemcitabine—kidney cancer	5.88e-05	0.000225	CcSEcCtD
Cidofovir—Rash—Gemcitabine—kidney cancer	5.83e-05	0.000223	CcSEcCtD
Cidofovir—Dermatitis—Gemcitabine—kidney cancer	5.82e-05	0.000223	CcSEcCtD
Cidofovir—Headache—Gemcitabine—kidney cancer	5.79e-05	0.000222	CcSEcCtD
Cidofovir—Nausea—Vincristine—kidney cancer	5.79e-05	0.000222	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.78e-05	0.000222	CcSEcCtD
Cidofovir—Rhinitis—Doxorubicin—kidney cancer	5.78e-05	0.000221	CcSEcCtD
Cidofovir—Hepatitis—Doxorubicin—kidney cancer	5.76e-05	0.000221	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5.75e-05	0.00464	CbGpPWpGaD
Cidofovir—Insomnia—Capecitabine—kidney cancer	5.74e-05	0.00022	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.73e-05	0.00463	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.73e-05	0.00463	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.73e-05	0.00463	CbGpPWpGaD
Cidofovir—Pharyngitis—Doxorubicin—kidney cancer	5.72e-05	0.000219	CcSEcCtD
Cidofovir—Paraesthesia—Capecitabine—kidney cancer	5.7e-05	0.000218	CcSEcCtD
Cidofovir—Hypersensitivity—Paclitaxel—kidney cancer	5.7e-05	0.000218	CcSEcCtD
Cidofovir—Urinary tract disorder—Doxorubicin—kidney cancer	5.69e-05	0.000218	CcSEcCtD
Cidofovir—Oedema peripheral—Doxorubicin—kidney cancer	5.68e-05	0.000217	CcSEcCtD
Cidofovir—Dyspnoea—Capecitabine—kidney cancer	5.66e-05	0.000217	CcSEcCtD
Cidofovir—Urethral disorder—Doxorubicin—kidney cancer	5.65e-05	0.000216	CcSEcCtD
Cidofovir—TYMP—Metabolism—CRABP1—kidney cancer	5.6e-05	0.00452	CbGpPWpGaD
Cidofovir—Dyspepsia—Capecitabine—kidney cancer	5.59e-05	0.000214	CcSEcCtD
Cidofovir—Visual impairment—Doxorubicin—kidney cancer	5.55e-05	0.000213	CcSEcCtD
Cidofovir—Asthenia—Paclitaxel—kidney cancer	5.55e-05	0.000213	CcSEcCtD
Cidofovir—Decreased appetite—Capecitabine—kidney cancer	5.52e-05	0.000212	CcSEcCtD
Cidofovir—Nausea—Gemcitabine—kidney cancer	5.49e-05	0.00021	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Capecitabine—kidney cancer	5.48e-05	0.00021	CcSEcCtD
Cidofovir—Pruritus—Paclitaxel—kidney cancer	5.47e-05	0.00021	CcSEcCtD
Cidofovir—Erythema multiforme—Doxorubicin—kidney cancer	5.45e-05	0.000209	CcSEcCtD
Cidofovir—Pain—Capecitabine—kidney cancer	5.43e-05	0.000208	CcSEcCtD
Cidofovir—Constipation—Capecitabine—kidney cancer	5.43e-05	0.000208	CcSEcCtD
Cidofovir—Eye disorder—Doxorubicin—kidney cancer	5.38e-05	0.000206	CcSEcCtD
Cidofovir—Tinnitus—Doxorubicin—kidney cancer	5.37e-05	0.000206	CcSEcCtD
Cidofovir—Flushing—Doxorubicin—kidney cancer	5.35e-05	0.000205	CcSEcCtD
Cidofovir—Diarrhoea—Paclitaxel—kidney cancer	5.29e-05	0.000203	CcSEcCtD
Cidofovir—Feeling abnormal—Capecitabine—kidney cancer	5.23e-05	0.0002	CcSEcCtD
Cidofovir—Angiopathy—Doxorubicin—kidney cancer	5.23e-05	0.0002	CcSEcCtD
Cidofovir—TYMP—Metabolism—ITPR2—kidney cancer	5.21e-05	0.0042	CbGpPWpGaD
Cidofovir—Gastrointestinal pain—Capecitabine—kidney cancer	5.19e-05	0.000199	CcSEcCtD
Cidofovir—Mediastinal disorder—Doxorubicin—kidney cancer	5.19e-05	0.000199	CcSEcCtD
Cidofovir—Chills—Doxorubicin—kidney cancer	5.17e-05	0.000198	CcSEcCtD
Cidofovir—Dizziness—Paclitaxel—kidney cancer	5.12e-05	0.000196	CcSEcCtD
Cidofovir—Alopecia—Doxorubicin—kidney cancer	5.09e-05	0.000195	CcSEcCtD
Cidofovir—Urticaria—Capecitabine—kidney cancer	5.04e-05	0.000193	CcSEcCtD
Cidofovir—Abdominal pain—Capecitabine—kidney cancer	5.02e-05	0.000192	CcSEcCtD
Cidofovir—Body temperature increased—Capecitabine—kidney cancer	5.02e-05	0.000192	CcSEcCtD
Cidofovir—Flatulence—Doxorubicin—kidney cancer	4.94e-05	0.000189	CcSEcCtD
Cidofovir—Tension—Doxorubicin—kidney cancer	4.92e-05	0.000189	CcSEcCtD
Cidofovir—Vomiting—Paclitaxel—kidney cancer	4.92e-05	0.000189	CcSEcCtD
Cidofovir—Dysgeusia—Doxorubicin—kidney cancer	4.91e-05	0.000188	CcSEcCtD
Cidofovir—Rash—Paclitaxel—kidney cancer	4.88e-05	0.000187	CcSEcCtD
Cidofovir—Dermatitis—Paclitaxel—kidney cancer	4.87e-05	0.000187	CcSEcCtD
Cidofovir—Nervousness—Doxorubicin—kidney cancer	4.87e-05	0.000187	CcSEcCtD
Cidofovir—Back pain—Doxorubicin—kidney cancer	4.85e-05	0.000186	CcSEcCtD
Cidofovir—Headache—Paclitaxel—kidney cancer	4.85e-05	0.000186	CcSEcCtD
Cidofovir—Muscle spasms—Doxorubicin—kidney cancer	4.82e-05	0.000185	CcSEcCtD
Cidofovir—TYMP—Metabolism—GSTT1—kidney cancer	4.75e-05	0.00383	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ACHE—kidney cancer	4.75e-05	0.00383	CbGpPWpGaD
Cidofovir—Hypersensitivity—Capecitabine—kidney cancer	4.68e-05	0.000179	CcSEcCtD
Cidofovir—Ill-defined disorder—Doxorubicin—kidney cancer	4.65e-05	0.000178	CcSEcCtD
Cidofovir—Anaemia—Doxorubicin—kidney cancer	4.64e-05	0.000178	CcSEcCtD
Cidofovir—Agitation—Doxorubicin—kidney cancer	4.61e-05	0.000177	CcSEcCtD
Cidofovir—Nausea—Paclitaxel—kidney cancer	4.6e-05	0.000176	CcSEcCtD
Cidofovir—Asthenia—Capecitabine—kidney cancer	4.56e-05	0.000175	CcSEcCtD
Cidofovir—Malaise—Doxorubicin—kidney cancer	4.52e-05	0.000173	CcSEcCtD
Cidofovir—Vertigo—Doxorubicin—kidney cancer	4.51e-05	0.000173	CcSEcCtD
Cidofovir—Syncope—Doxorubicin—kidney cancer	4.5e-05	0.000172	CcSEcCtD
Cidofovir—TYMP—Metabolism—SCARB1—kidney cancer	4.5e-05	0.00363	CbGpPWpGaD
Cidofovir—Pruritus—Capecitabine—kidney cancer	4.49e-05	0.000172	CcSEcCtD
Cidofovir—Leukopenia—Doxorubicin—kidney cancer	4.49e-05	0.000172	CcSEcCtD
Cidofovir—TYMP—Metabolism—PTGS1—kidney cancer	4.45e-05	0.00359	CbGpPWpGaD
Cidofovir—Loss of consciousness—Doxorubicin—kidney cancer	4.41e-05	0.000169	CcSEcCtD
Cidofovir—Cough—Doxorubicin—kidney cancer	4.38e-05	0.000168	CcSEcCtD
Cidofovir—TYMP—Metabolism—PSMD7—kidney cancer	4.36e-05	0.00352	CbGpPWpGaD
Cidofovir—Convulsion—Doxorubicin—kidney cancer	4.35e-05	0.000166	CcSEcCtD
Cidofovir—Diarrhoea—Capecitabine—kidney cancer	4.34e-05	0.000166	CcSEcCtD
Cidofovir—Hypertension—Doxorubicin—kidney cancer	4.33e-05	0.000166	CcSEcCtD
Cidofovir—Myalgia—Doxorubicin—kidney cancer	4.27e-05	0.000164	CcSEcCtD
Cidofovir—Chest pain—Doxorubicin—kidney cancer	4.27e-05	0.000164	CcSEcCtD
Cidofovir—Arthralgia—Doxorubicin—kidney cancer	4.27e-05	0.000164	CcSEcCtD
Cidofovir—Anxiety—Doxorubicin—kidney cancer	4.25e-05	0.000163	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.24e-05	0.000162	CcSEcCtD
Cidofovir—Discomfort—Doxorubicin—kidney cancer	4.22e-05	0.000162	CcSEcCtD
Cidofovir—Dizziness—Capecitabine—kidney cancer	4.2e-05	0.000161	CcSEcCtD
Cidofovir—Dry mouth—Doxorubicin—kidney cancer	4.18e-05	0.00016	CcSEcCtD
Cidofovir—TYMP—Metabolism—BCHE—kidney cancer	4.14e-05	0.00334	CbGpPWpGaD
Cidofovir—Confusional state—Doxorubicin—kidney cancer	4.13e-05	0.000158	CcSEcCtD
Cidofovir—Anaphylactic shock—Doxorubicin—kidney cancer	4.09e-05	0.000157	CcSEcCtD
Cidofovir—Oedema—Doxorubicin—kidney cancer	4.09e-05	0.000157	CcSEcCtD
Cidofovir—TYMP—Metabolism—SLC5A5—kidney cancer	4.09e-05	0.0033	CbGpPWpGaD
Cidofovir—Infection—Doxorubicin—kidney cancer	4.07e-05	0.000156	CcSEcCtD
Cidofovir—Vomiting—Capecitabine—kidney cancer	4.04e-05	0.000155	CcSEcCtD
Cidofovir—Shock—Doxorubicin—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Cidofovir—Nervous system disorder—Doxorubicin—kidney cancer	4.01e-05	0.000154	CcSEcCtD
Cidofovir—Thrombocytopenia—Doxorubicin—kidney cancer	4.01e-05	0.000154	CcSEcCtD
Cidofovir—Rash—Capecitabine—kidney cancer	4e-05	0.000153	CcSEcCtD
Cidofovir—Dermatitis—Capecitabine—kidney cancer	4e-05	0.000153	CcSEcCtD
Cidofovir—Tachycardia—Doxorubicin—kidney cancer	3.99e-05	0.000153	CcSEcCtD
Cidofovir—Headache—Capecitabine—kidney cancer	3.98e-05	0.000152	CcSEcCtD
Cidofovir—Skin disorder—Doxorubicin—kidney cancer	3.98e-05	0.000152	CcSEcCtD
Cidofovir—Hyperhidrosis—Doxorubicin—kidney cancer	3.96e-05	0.000152	CcSEcCtD
Cidofovir—TYMP—Metabolism—SLC2A1—kidney cancer	3.95e-05	0.00318	CbGpPWpGaD
Cidofovir—Anorexia—Doxorubicin—kidney cancer	3.9e-05	0.000149	CcSEcCtD
Cidofovir—Hypotension—Doxorubicin—kidney cancer	3.82e-05	0.000147	CcSEcCtD
Cidofovir—Nausea—Capecitabine—kidney cancer	3.77e-05	0.000145	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.73e-05	0.000143	CcSEcCtD
Cidofovir—Insomnia—Doxorubicin—kidney cancer	3.7e-05	0.000142	CcSEcCtD
Cidofovir—Paraesthesia—Doxorubicin—kidney cancer	3.68e-05	0.000141	CcSEcCtD
Cidofovir—Dyspnoea—Doxorubicin—kidney cancer	3.65e-05	0.00014	CcSEcCtD
Cidofovir—Somnolence—Doxorubicin—kidney cancer	3.64e-05	0.000139	CcSEcCtD
Cidofovir—Dyspepsia—Doxorubicin—kidney cancer	3.6e-05	0.000138	CcSEcCtD
Cidofovir—Decreased appetite—Doxorubicin—kidney cancer	3.56e-05	0.000136	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.53e-05	0.000135	CcSEcCtD
Cidofovir—Constipation—Doxorubicin—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Cidofovir—Pain—Doxorubicin—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Cidofovir—Feeling abnormal—Doxorubicin—kidney cancer	3.37e-05	0.000129	CcSEcCtD
Cidofovir—Gastrointestinal pain—Doxorubicin—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Cidofovir—TYMP—Metabolism—GSTP1—kidney cancer	3.29e-05	0.00266	CbGpPWpGaD
Cidofovir—Urticaria—Doxorubicin—kidney cancer	3.25e-05	0.000125	CcSEcCtD
Cidofovir—Abdominal pain—Doxorubicin—kidney cancer	3.24e-05	0.000124	CcSEcCtD
Cidofovir—Body temperature increased—Doxorubicin—kidney cancer	3.24e-05	0.000124	CcSEcCtD
Cidofovir—TYMP—Metabolism—ABCB1—kidney cancer	3.12e-05	0.00251	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTM1—kidney cancer	3.03e-05	0.00244	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.02e-05	0.00244	CbGpPWpGaD
Cidofovir—Hypersensitivity—Doxorubicin—kidney cancer	3.02e-05	0.000116	CcSEcCtD
Cidofovir—Asthenia—Doxorubicin—kidney cancer	2.94e-05	0.000113	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.92e-05	0.00236	CbGpPWpGaD
Cidofovir—Pruritus—Doxorubicin—kidney cancer	2.9e-05	0.000111	CcSEcCtD
Cidofovir—TYMP—Metabolism—CYP1A1—kidney cancer	2.87e-05	0.00231	CbGpPWpGaD
Cidofovir—Diarrhoea—Doxorubicin—kidney cancer	2.8e-05	0.000107	CcSEcCtD
Cidofovir—Dizziness—Doxorubicin—kidney cancer	2.71e-05	0.000104	CcSEcCtD
Cidofovir—Vomiting—Doxorubicin—kidney cancer	2.6e-05	9.97e-05	CcSEcCtD
Cidofovir—Rash—Doxorubicin—kidney cancer	2.58e-05	9.89e-05	CcSEcCtD
Cidofovir—Dermatitis—Doxorubicin—kidney cancer	2.58e-05	9.88e-05	CcSEcCtD
Cidofovir—Headache—Doxorubicin—kidney cancer	2.56e-05	9.83e-05	CcSEcCtD
Cidofovir—Nausea—Doxorubicin—kidney cancer	2.43e-05	9.32e-05	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.31e-05	0.00186	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—POMC—kidney cancer	2.14e-05	0.00173	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTGS2—kidney cancer	1.71e-05	0.00138	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTEN—kidney cancer	1.49e-05	0.0012	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.3e-05	0.00105	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PIK3CA—kidney cancer	1.05e-05	0.000847	CbGpPWpGaD
